iShares US Medical Devices
Latest iShares US Medical Devices News and Updates
What to Expect from St. Jude Medical’s Earnings in 2Q16
In 1Q16, St. Jude Medical exceeded analysts’ EPS (earnings per share) estimate of $0.89 as well as the revenue estimate of ~$1.4 billion.
ALGN Stock Surpasses the S&P 500 Index’s Year-to-Date Gain
On September 28, Align Technology (ALGN) posted an ~74% increase year-to-date. In the same period, the S&P 500 Index has returned ~9%.
Abbott Laboratories Traded at a 52-Week High after Posting Strong 4Q17 Results
On January 29, 2018, Abbott Laboratories (ABT) closed trading at $63.31 per share. The company reported its 52-week high of $64.60 on January 25.
How Are Stryker’s Core Strategies Working Toward Its Growth?
Stryker (SYK) registered strong 3Q16 earnings on October 27, 2016. The company’s reported earnings exceeded analysts’ estimates.
BD’s Stock Price Performance after Recent 52-Week High
On December 28, Becton, Dickinson and Company (BDX), or BD, closed trading on the day at $214.32 per share. Currently, BD stock’s 50-day moving average stands at $221.22.
Abbott Laboratories’ Stock Performance after a Recent Bull Run
On February 16, Abbott Laboratories (ABT) closed trading at $60.17 per share.
Abbott Laboratories’ Stock Price Performance in July
Year-to-date, ABT stock has risen 12.8%. Over the last month, the stock has returned ~4.0%.
How Has Boston Scientific Stock Performed Recently?
Boston Scientific (BSX) was trading at $27.9 on June 29, 2017.
BSX Stock Regains Momentum after Its Recent Bearish Trend
On February 14, 2018, Boston Scientific stock closed the day at $26.81. The stock was trading near its 50-day moving average of $26.82.
Stryker’s Recent Stock Price Movement: Upside Potential?
Stryker stock has registered slightly volatile activity in the past few months. However, the stock largely remains on a bullish trajectory.
A Look at Medtronic’s Recent Stock Performance
Medtronic (MDT) was trading at $83.9 on May 22, 2017. It had a 50-day moving average of $82.1 and a 200-day moving average of $78.4.
Effect of Claris Injectables Acquisition on Baxter’s 2017 Growth
On July 27, 2017, Baxter International (BAX) completed the acquisition of Claris Injectables, which is expected to help expand and strengthen Baxter’s core capabilities.
Must-know: Key export barriers for medical device manufacturers
Most large U.S. manufacturers have invested significant capital into emerging markets, including Medtronics, Johnson & Johnson, GE, and Stryker.
Illumina Stock Continues Its Bull Run
Illumina (ILMN) reached a 52-week high of $357.93 per share on August 31.
Brazil’s medical device industry: Health coverage outlook
The upward trends of the healthcare market show that Brazil is positive for the medical device industry, suggesting rapid increases in demand as more and more people can afford the devices and pay accordingly.
What Can We Expect for Stryker’s Earnings in 2Q16?
In 1Q16, Stryker exceeded analysts’ EPS (earnings per share) estimate of $1.20, as well as the revenue estimate of ~$2.5 billion.
A Look at Medtronic’s Earnings Trends and Guidance for Fiscal 2019
Medtronic (MDT) reported net income of $1.1 billion in the second quarter of fiscal 2019 compared to $2.0 billion in the second quarter of fiscal 2018.
How Does Medtronic’s Restorative Therapies & Diabetes Group Look?
Medtronic’s Restorative Therapies Group consists of Spine, Brain, Specialty and Pain therapies.
Why Analysts Are Mostly Positive on Boston Scientific Stock
Boston Scientific stock rose from $24.79 at the close of market on December 29, 2017, to $34.80 at the close of market on November 23.
Intuitive Surgical Stock Has Seen Growth of 34% Year-to-Date
Intuitive Surgical’s stock price rose from $364.94 at the close of market on December 29, 2017, to $489.57 on November 23, 2018.
Thermo Fisher Beats Analysts’ Estimates in Q3 2018 Earnings
Thermo Fisher Scientific (TMO) reported its third-quarter results today. It surpassed analysts’ estimates for EPS and revenue.
Thermo Fisher’s Third-Quarter Revenue Estimates
The Life Sciences Solutions segment, including reagents, instruments, and consumables, contributes ~25% of Thermo Fisher’s total revenues.
Zimmer Biomet Holdings: Revenue Trends ahead of Its Q3 Earnings
Zimmer Biomet (ZBH) plans to release its Q3 earnings on October 26. Analysts expect ZBH to generate third-quarter revenues of $1.8 billion.
EW Stock Returned More than the S&P 500’s Gain in 2018
As of September 28, Edwards Lifesciences (EW) has registered a rise of ~52.5% YTD (year-to-date). In the same period, the S&P 500 has risen ~9.2%.
ABT Returns Almost Double the S&P 500’s Year-to-Date Gain
As of September 19, Abbott Laboratories (ABT) has registered a rise of ~17% YTD (year-to-date).
How Thermo Fisher Scientific’s Valuation Looks in September
Thermo Fisher Scientific currently trades at a forward PE multiple of ~19.9x.
What Analysts Expect for Abiomed
Wall Street analysts estimate Abiomed (ABMD) will report 29.9% growth in revenues to ~$771.0 million in 2019 as compared to $593.7 million in 2018.
Reading Dentsply Sirona’s Recent Stock Performance
On March 13, 2018, Dentsply Sirona closed trading at a price of $57.80 per share. The stock registered its 52-week high of $68.98 on November 28, 2017.
BSX Stock Rises More Than 2% Following EMcision Acquisition
Boston Scientific’s recent stock performance On March 6, 2018, Boston Scientific (BSX) stock closed at $27.41, higher than its 50-day moving average of $27.15 and lower than its 200-day moving average of $27.52. As of March 7, 2018, Boston Scientific’s 52-week high was $29.93 on October 23, 2017, and its 52-week low was $24.02 on March 22, 2017. Factors […]
Where Is SYK Stock Headed after Its Recent All-Time Highs?
On February 26, 2018, Stryker (SYK) closed trading at $165.77. The stock was trading at its all-time high of $170 on January 29, 2018.
What Analysts Recommend for Medtronic ahead of 3Q18 Earnings
Medtronic (MDT) plans to release its 3Q18 earnings results on February 20, 2018.
How BD Stock Has Performed in the Last Year
On February 6, 2018, BD released its 1Q18 earnings results, which came in ahead of expectations.
BD Medical Segment Posted Strong Fiscal 1Q18 Performance
In fiscal 1Q18, BDX’s Medication and Procedural Solutions business registered sales growth of 5.0%.
Rationale behind Varian Medical’s Acquisition of Sirtex Medical
On January 30, 2018, Varian Medical Systems (VAR) announced that it had entered into an agreement to acquire Sirtex Medical Limited for $1.3 billion.
ABT Stock Trading Near Its All-Time High: What’s Driving Growth?
Abbott Laboratories (ABT) is currently trading near its all-time high of $59.60 per share, which was reported on January 4, 2018.
Stryker’s Stock Rally Continues with 52-Week High Yesterday
On January 9, Stryker (SYK) traded at a 52-week high of $164.2 per share. The stock ended trading with a closing price of $160.4.
Discussing Baxter International’s Recent Stock Price Highs
On January 4, 2018, Baxter International was trading at a 52-week high of $68.86 per share, ending the day at $68.41 per share.
A Look at Thermo Fisher Scientific’s Recent Stock Price Performance
TMO stock reported its 52-week high of $201.20 on October 26, 2017, when the company released its 3Q17 earnings results.
TMO’s Acquisition from EPTEK Technology Could Boost Its China Opportunity
On December 4, 2017, Thermo Fisher Scientific (TMO) completed the acquisition of some assets from EPTEK Technology and related entities that have offices in mainland China and Taiwan.
How the Corporate Tax Rate Cut Could Affect R&D in the Medtech Industry
The repeal of the tax deduction for high medical expenses may reduce the number of taxpayers opting for costly medical technologies and services.
Understanding BD’s Recent Stock Performance
BD has a 50-day moving average of $197.25, while its 200-day moving average is $192.35.
Inside Baxter International’s Stock Price Performance
On September 7, 2017, BAX stock closed at $62.84 per share. It has a 50-day moving average of $61.15 and a 200-day moving average of $57.14.
Edwards Lifesciences Near 52-Week High: Can It Sustain Momentum?
Edwards Lifesciences (EW), a leader in the artificial heart valve market, has been expanding rapidly amid its new product launches and innovative product pipeline.
Boston Scientific Is Accelerating Category Leadership Strategy
Boston Scientific (BSX) currently has a global market opportunity of $40.0 billion, which is expected to grow to $50.0 billion by fiscal 2020.
What’s Behind the Recent Slump in ZBH Stock Price?
Zimmer Biomet closed trading at price of $113.1 on August 30. The stock has a 50-day moving average of $119.95 and a 200-day moving average of $120.95.
Taking a Look at Stryker’s Recent Stock Price Performance
On August 31, Stryker (SYK) closed trading at a closing price of $139.3. It has a 50-day moving average of $144.7 and a 200-day moving average of $137.5.
How Medtronic Is Accelerating Its Economic Value Growth Strategy
Medtronic’s (MDT) Hospital Solutions segment registered double-digit growth in fiscal 1Q18.
Key Highlights of Varian Medical Systems’ Fiscal 2Q17 Earnings
On April 26, 2016, Varian Medical Systems (VAR) released its 2Q17 earnings. VAR beat consensus estimates for revenues in 2Q17 by ~0.8% and reported in-line earnings per share.
Key Drivers behind BDX’s Recent Stock Performance
BDX has a 50-day moving average of $196.80 and a 200-day moving average of $185.70.
What to Expect from Intuitive Surgical’s 2Q17 Earnings
Analysts estimate that Intuitive Surgical will post 2Q17 EPS (earnings per share) of ~$4.76. In 1Q17, Intuitive Surgical exceeded analysts’ diluted EPS estimate of $4.67.
Behind BD’s Recent New Stock Price High
BD (BDX) closed trading at $195.3 on July 6, 2017, ahead of its 50-day moving average of $191.3 and its 200-day moving average of $181.9.
A Look at Abbott Laboratories Stock for 2Q17
Wall Street analysts estimate that Abbott Laboratories (ABT) stock has the potential to return ~6.1% over the next 12 months.
Varian Medical Systems: Analyzing Its Stock Performance
Varian Medical Systems (VAR) was trading at $102.7 on June 29, 2017. It has a 50-day moving average of $100.4 and a 200-day moving average of $88.8.
FDA Warning Letter to Zimmer Biomet Resolved, Boosts Confidence
On June 13, 2017, Zimmer Biomet (ZBH) announced that the FDA warning letter issued in June 2015 relating to its Zhejiang manufacturing facility in China has been closed.
Health Sector Overview: Week of June 5–9, 2017
In the week ending June 9, 2017, the Health Care Select Sector SPDR Fund (XLV) saw a rise of 0.13%.
Behind Thermo Fisher’s Recent Stock Performance
TMO stock was trading at $173.2 on May 30, 2017. The stock had a 50-day moving average of $165.9 and a 200-day moving average of $153.8 that day.
How Zimmer Biomet Stock Has Performed Recently
Zimmer Biomet Holdings (ZBH) was trading at $118.40 on May 30, 2017. It has a 50-day moving average of $119.70 and a 200-day moving average of $114.20.
Medtronic’s Strong 4Q17 Profits Beat Analyst Expectations
Medtronic (MDT) reported an operating margin of 30.7% of total sales in fiscal 4Q17 on a constant currency basis.
What Do Analysts Recommend for Boston Scientific?
Let’s look at Wall Street analysts’ recommendations and target prices for Boston Scientific (BSX) over the next 12 months.
Trump Trade Fades amid Political Debacle: What’s the Impact?
As part of Obamacare, a medical device tax of 2.3% has been implemented on medical device companies in the United States.
What Analysts Recommend for Stryker after 1Q17 Results
The consensus 12-month target price for Stryker is $141, a ~3.5% return potential.
FTC Approved Abbott’s Acquisition of St. Jude Medical
The FTC (Federal Trade Commission) has approved the $25 billion acquisition of St. Jude Medical (STJ) by Abbott Laboratories (ABT) subject to certain conditions.
Not Much to Brag About for Emerson’s Industrial Automation Unit
Revenues for Emerson’s Industrial Automation segment have fallen from $5.3 billion in 2011 to $4.1 billion in 2015.
How Danaher Diagnostics Fares against Its Competition
Danaher’s Diagnostics unit had operating margins of 15.4% in 2015 and 17.2% in 1H16.
Understanding the Skeleton of Danaher’s Life Sciences Business
Customers in the Danaher life sciences business generally look at how the technology offered by a company can fit into their workflows.
How Are Danaher’s Returns Compared to Its Industry Peers’?
Danaher’s ROIC fell steadily from 15.5% in 2006 to 8.5% in 2015, indicating that it has probably had fewer high return reinvestment opportunities since then.
Understanding Thermo Fisher Scientific’s Financial Model
Thermo Fisher Scientific aims to deliver adjusted EPS in the range of $11.3–$12.2 by 2019. This represents a three-year CAGR of 12%–15%.
IHI’s Holdings: How Are Moving Averages Trending?
As of June 2, 2016, 91% of IHI’s stocks were trading above their 20-day moving averages, 79% above their 50-day moving averages, and 89% above their 100-day moving averages.
Profit Booking Leaves the iShares US Medical Devices ETF (IHI) in the Red
On May 19, markets declined, with the SPDR S&P 500 ETF dropping by 0.3% and the iShares US Medical Devices ETF (IHI) declining by 0.8%.
What’s behind the US Economy’s Remarkable Labor Market Strength?
The US labor market has shown tremendous resilience amid concerns over various issues, like aging demographics.
Inside IHI’s Large-Caps: Becton Dickinson Rose on Good 2Q16
Becton Dickinson (BDX) announced its 2Q16 earnings on May 5, 2016. Becton Dickinson closed at $160.43 and was trading above the 20-day moving average. The stock has risen 4.1% YTD.
IHI Large-Caps: Baxter Launches Mobile Health App in India
In a press release, Baxter International (BAX) announced that it has launched a new mobile app in India called Sisu Janani Seva. It’s also known as mHealth.
Analyzing Medtronic’s Acquisition of Covidien
Medtronic’s (MDT) acquisition of Covidien in January 2016 positioned the company as the biggest player in the medical device industry.
Behind Becton Dickinson’s Strategic Restructuring and Business Consolidation
To better position itself amid the changing medical device environment, Becton Dickinson has come to focus on restructuring and business model evolution.
IHI: Which of Its Holdings Was the Top Performer?
In this article, we’ll analyze the YTD (year-to-date) performances of the top five holdings of the iShares US Medical Device ETF (IHI).
How Has Technology Influenced Process and Product Innovation?
One of the most prominent effects of technology is on the asset side of the balance sheet. Many technologies drive companies to employ fewer assets in order to generate higher returns.
How a Strong Product Portfolio Drives Thermo Fisher’s Valuations
Thermo Fisher Scientific (TMO) registered sales of $4.7 billion, representing year-over-year growth of 4% in 4Q15 and fiscal 2015 sales of ~$17 billion.
An Overview of Thermo Fisher Scientific’s Business Model
Thermo Fisher Scientific (TMO) has made a number of acquisitions over the years, resulting in the expansion of the company’s product portfolio with the inclusion of a number of premium brands.
Latest Consensus Recommendation for Medtronic: Strong “Buy”
Medtronic is set to release its fiscal 3Q16 earnings results on March 1, 2016. About 76.9% of companies have rated Medtronic as a “buy.”
Becton, Dickinson and Company’s Latest Analyst Recommendations
Becton, Dickinson and Company (BDX), or BD, is set to release its 1Q16 earnings results on February 3, 2016.
Abbott Laboratories’ Latest Analyst Recommendations
In a Bloomberg survey of 24 brokerage firms, as recorded on January 18, 2016, about 70.8% of firms have rated Abbott Laboratories a “buy,” and 29.2% of firms have rated the company a “hold.
Thermo Fisher Scientific: A Leading Medical Technology Company
Thermo Fisher Scientific (TMO) is one of the leading medical technology companies in the world, providing a broad portfolio of laboratory equipment and services.
A Key Look at Abbott Laboratories’ Acquisitions and Divestments
Inorganic growth through acquisitions has led to the expansion of Abbott Laboratories across geographies and to the broadening of its product portfolio.
Established Pharmaceuticals Segment of Abbott Laboratories
Abbott’s Established Pharmaceuticals segment is a consumer-oriented segment with a consumer mix of around 75% self-pay consumers and 25% third-party payers.
A Look at Becton, Dickinson and Company’s Valuation
Becton, Dickinson and Company is one of the five biggest medical device companies in the United States.
Introducing Abbott Laboratories, a Leading Global Healthcare Company
Abbott Laboratories operates across more than 150 countries, employs over 73,000 people, and is the global leader in the nutrition subsector.
Becton, Dickinson and Company’s Acquisitions and Collaborations
Becton, Dickinson and Company’s (BDX), or BD’s, growth strategy includes acquisitions and collaborations.
Becton, Dickinson and Company: A Leading Global Medical Device Company
Becton, Dickinson and Company, or BD, headquartered in Franklin Lakes, New Jersey, is one of the leading medical technology companies in the United States.
Why Technology Is a Key Driver in the US Medical Device Industry
Traditionally, the United States has been home to the most advanced technological inventions in the medical device industry.
How Economic and Demographic Factors Affect Medical Device Industry
Though the medical device sector displays significant resilience towards changes in the economic environment, economic factors do impact short-term demand substantially.
What Are the Medical Device Approval Processes in Major Markets?
In most countries, the approval process varies across different categories of devices classified as per their risk profiles.
How the Dynamics Are Changing in the Medical Device Industry
The medical device industry consists of a few big manufacturing companies that dominate the market and a large number of small players.
Why Are Patents Necessary for Medical Device Companies?
Medical device companies are driven by innovation and inventions that involve high research and development (or R&D) costs.
How Reimbursement Models Impact the Medical Device Industry
Coverage, coding, and payment are essential elements to obtaining adequate reimbursement for a new medical device.
Analyzing the Competitive Landscape of the Medical Device Industry
The medical device industry in the US consists of a few big players and a large number of small and medium enterprises.
How Is the US Medical Device Industry Performing in Emerging Markets?
US medical device exports were worth $45 billion against the medical device industry’s global market value of $340 billion in 2014.
How Does the FDA Classify Medical Devices?
Medical devices are classified as per the level of control required by the Food, Drug, and Cosmetic Act (or FD&C Act).
How Is the US Medical Device Industry Valued?
The US medical device industry has rebounded sharply since its 2008 decline, and it is trading at a high PE of 21.9x.
What Are the Major US Medical Device Industry ETFs?
Funds like the Healthcare Select Sector SPDR ETF (or XLV) provide exposure of approximately 16% to the medical device industry.
How Do Commodity Prices Impact the Medical Device Industry?
Medical device manufacturers source various medical components and parts from suppliers in order to assemble or develop medical devices.